Karakus, I. S. Et Al. 2024. Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.. Journal of clinical immunology , vol.44, no.4 , 94.

Karakus, I. S., Catak, M. C., Frohne, A., Bayram Catak, F., Yorgun Altunbas, M., Babayeva, R., ... Bal, S. K.(2024). Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.. Journal of clinical immunology , vol.44, no.4, 94.

Karakus, Ibrahim Et Al. "Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.," Journal of clinical immunology , vol.44, no.4, 94, 2024

Karakus, Ibrahim S. Et Al. "Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.." Journal of clinical immunology , vol.44, no.4, pp.94, 2024

Karakus, I. S. Et Al. (2024) . "Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.." Journal of clinical immunology , vol.44, no.4, p.94.

@article{article, author={Ibrahim Serhat Karakus Et Al. }, title={Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.}, journal={Journal of clinical immunology}, year=2024, pages={94} }